The effect and tolerance with co-administration of nateglinide and insulin glargine in type 2 diabetes
DI Wenjuan
Abstract
DI Wenjuan
Abstract
Objective To evaluate the effect and tolerance of co-administration of nateglinide and insulin glargine in type 2 diabetes(T2DM).Methods The fasting blood glucose(FBG),postprandial blood glucose(BG),glycosylated hemoglobin(HbA) and the undulation of blood glucose with co-administration of nateglinide and insulin glargine were evaluated in 57 T2DM greater than 60 yrars old.Results Compared to beforetreatment,BG was significantly decreased after co-administration of nateglinide and insulin glargine before breakfast,at 2 hours after lunch and supper and before retiring(P0.05),which was more at 2 hours after breakfast and before lunch(P0.01).There was a tendency of decrease in BG before supper and at 3 AM in the early morning(P0.05).Conclusion Nateglinide combined with insulin glargine can be used effectively and safely to treat T2DM patients aged greater than 60 yrars old.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the effect and tolerance of co-administration of nateglinide and insulin glargine in type 2 diabetes(T2DM).Methods The fasting blood glucose(FBG),postprandial blood glucose(BG),glycosylated hemoglobin(HbA) and the undulation of blood glucose with co-administration of nateglinide and insulin glargine were evaluated in 57 T2DM greater than 60 yrars old.Results Compared to beforetreatment,BG was significantly decreased after co-administration of nateglinide and insulin glargine before breakfast,at 2 hours after lunch and supper and before retiring(P0.05),which was more at 2 hours after breakfast and before lunch(P0.01).There was a tendency of decrease in BG before supper and at 3 AM in the early morning(P0.05).Conclusion Nateglinide combined with insulin glargine can be used effectively and safely to treat T2DM patients aged greater than 60 yrars old.
Key concepts: Nateglinide, Medicine, Insulin glargine, Postprandial, Type 2 diabetes, Internal medicine, Morning, Endocrinology